These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37421455)

  • 21. Identification of RNA Methylation-Related lncRNAs Signature for Predicting Hot and Cold Tumors and Prognosis in Colon Cancer.
    He R; Man C; Huang J; He L; Wang X; Lang Y; Fan Y
    Front Genet; 2022; 13():870945. PubMed ID: 35464855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma.
    Wang J; Ren H; Xu C; Yu B; Cai Y; Wang J; Ni X
    Sci Rep; 2024 Apr; 14(1):8238. PubMed ID: 38589454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping the m1A, m5C, m6A and m7G methylation atlas in zebrafish brain under hypoxic conditions by MeRIP-seq.
    Li W; Li X; Ma X; Xiao W; Zhang J
    BMC Genomics; 2022 Feb; 23(1):105. PubMed ID: 35135476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
    Zheng P; Li N; Zhan X
    Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
    Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
    BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
    Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
    Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
    Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
    Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma.
    Bao G; Li T; Guan X; Yao Y; Liang J; Xiang Y; Zhong X
    Front Oncol; 2022; 12():882292. PubMed ID: 35712502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of the expression and prognostic significance of m
    Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G
    Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m5C RNA Methylation Regulators Predict Prognosis and Regulate the Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Pan J; Huang Z; Xu Y
    Front Oncol; 2021; 11():657466. PubMed ID: 34195072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma.
    Ji J; Liu S; Liang Y; Zheng G
    BMC Genom Data; 2023 Aug; 24(1):44. PubMed ID: 37568073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Analysis of the Prognostic Value and Immune Infiltrates of the Three-m5C Signature in Colon Carcinoma.
    Geng Q; Wei Q; Shen Z; Zheng Y; Wang L; Xue W; Li L; Zhao J
    Cancer Manag Res; 2021; 13():7989-8002. PubMed ID: 34707405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated Analyses of m6A Regulator-Based Signature on Its Clinical Application and Immunogenomic Landscape in Stomach Adenocarcinoma.
    Zhang L; Zhang Q; Huang Z; Zhu M; Wang T; Zhu W; Wang X; Zhou X
    Biomed Res Int; 2022; 2022():2053719. PubMed ID: 36193316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive analysis of m
    Zhao K; Li W; Yang Y; Hu X; Dai Y; Huang M; Luo J; Zhang K; Zhao N
    Front Immunol; 2022; 13():955848. PubMed ID: 36203569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.
    Liu X; Ma C; Liu H; Sun Z; Luo J
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation.
    Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D
    Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of m5C regulators in sarcoma can guide different immune infiltrations as well as immunotherapy.
    Wu S; Li M; Su R; Shen H; He Y; Zhou Y
    Front Surg; 2022; 9():948371. PubMed ID: 36684288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.
    Zhao M; Shen S; Xue C
    Front Immunol; 2022; 13():805967. PubMed ID: 35401564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
    Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
    Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.